# Arrive AI Inc.: financial statements, quarterly

ARAI · Nasdaq · CIK 1818274 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/arai.md) · [Financials](/companies/arai/financials.md) · [Filings](/companies/arai/filings.md) · [Insiders](/companies/arai/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/arai/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | [0.1](/filings/0001493152-26-037755.md) | [0.0](/filings/0001493152-26-016857.md) | [0.0 d](/filings/0001493152-26-016808.md) | [0.0](/filings/0001493152-26-023747.md) | [0.0](/filings/0001493152-26-037755.md) |
| Research and development | $m | [0.1](/filings/0001641172-25-013826.md) | [0.5](/filings/0001493152-26-016849.md) | [0.0](/filings/0001493152-26-016857.md) | [0.2 d](/filings/0001493152-26-016808.md) | [0.1](/filings/0001493152-26-023747.md) | [0.3](/filings/0001493152-26-037755.md) | [0.2](/filings/0001493152-26-016857.md) | [0.0 d](/filings/0001493152-26-016808.md) | [0.4](/filings/0001493152-26-023747.md) | [0.3](/filings/0001493152-26-037755.md) |
| Interest expense | $m | [0.0](/filings/0001641172-25-013826.md) | not reported | not reported | not reported | [0.0](/filings/0001641172-25-013826.md) | not reported | [0.2](/filings/0001493152-25-023457.md) | not reported | not reported | not reported |
| Net income | $m | [(0.9)](/filings/0001493152-26-016857.md) | [(1.5)](/filings/0001493152-26-016857.md) | [(0.8)](/filings/0001493152-26-016857.md) | [(1.3) d](/filings/0001493152-26-016808.md) | [(2.0)](/filings/0001493152-26-037755.md) | [(3.7)](/filings/0001493152-26-037755.md) | [(4.4)](/filings/0001493152-26-016857.md) | [(2.7) d](/filings/0001493152-26-016808.md) | [(6.4)](/filings/0001493152-26-037755.md) | [(14.1)](/filings/0001493152-26-037755.md) |
| Diluted EPS | $ per share | [(0.03)](/filings/0001641172-25-013826.md) | [(0.05)](/filings/0001493152-26-016849.md) | [(0.03)](/filings/0001493152-26-016857.md) | not reported | [(0.07)](/filings/0001493152-26-023747.md) | [(0.12)](/filings/0001493152-26-037755.md) | [(0.13)](/filings/0001493152-26-016857.md) | not reported | [(0.18)](/filings/0001493152-26-023747.md) | [(0.28)](/filings/0001493152-26-037755.md) |
| Basic EPS | $ per share | [(0.03)](/filings/0001641172-25-013826.md) | [(0.05)](/filings/0001493152-26-016849.md) | [(0.03)](/filings/0001493152-25-023457.md) | not reported | [(0.07)](/filings/0001493152-26-023747.md) | [(0.12)](/filings/0001493152-26-037755.md) | [(0.13)](/filings/0001493152-26-016857.md) | not reported | [(0.18)](/filings/0001493152-26-023747.md) | [(0.28)](/filings/0001493152-26-037755.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | period not labelled (2026-08-13) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | [0.1](/filings/0001493152-26-016857.md) | [0.3](/filings/0001641172-25-013826.md) | [0.6](/filings/0001493152-26-016849.md) | [0.8](/filings/0001493152-26-016857.md) | [2.1](/filings/0001493152-26-037755.md) | [5.1](/filings/0001493152-26-023747.md) | [3.0](/filings/0001493152-26-037755.md) | [3.0](/filings/0001493152-26-037755.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | [0.6](/filings/0001493152-26-016857.md) | [7.7](/filings/0001641172-25-013826.md) | [0.9](/filings/0001493152-26-016849.md) | [2.9](/filings/0001493152-26-016857.md) | [2.3](/filings/0001493152-26-037755.md) | [8.8](/filings/0001493152-26-023747.md) | [5.7](/filings/0001493152-26-037755.md) | not reported |
| Total assets | $m | not reported | not reported | not reported | not reported | [1.0](/filings/0001493152-26-016857.md) | [8.1](/filings/0001641172-25-013826.md) | [8.5](/filings/0001493152-26-016849.md) | [9.7](/filings/0001493152-26-016857.md) | [10.9](/filings/0001493152-26-037755.md) | [15.5](/filings/0001493152-26-023747.md) | [12.4](/filings/0001493152-26-037755.md) | not reported |
| Current liabilities | $m | not reported | not reported | not reported | not reported | [2.0](/filings/0001493152-26-016857.md) | [2.0](/filings/0001641172-25-013826.md) | [4.0](/filings/0001493152-26-016849.md) | [4.0](/filings/0001493152-26-016857.md) | [6.7](/filings/0001493152-26-037755.md) | [11.3](/filings/0001493152-26-023747.md) | [6.2](/filings/0001493152-26-037755.md) | not reported |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [2.0](/filings/0001493152-26-016857.md) | [2.0](/filings/0001641172-25-013826.md) | [4.0](/filings/0001493152-26-016849.md) | [4.0](/filings/0001493152-26-016857.md) | [8.5](/filings/0001493152-26-037755.md) | [12.9](/filings/0001493152-26-023747.md) | [7.7](/filings/0001493152-26-037755.md) | not reported |
| Shareholders' equity | $m | [(0.5)](/filings/0001493152-26-016857.md) | [(0.4)](/filings/0001493152-26-016857.md) | [(1.0)](/filings/0001493152-26-016857.md) | [(0.8)](/filings/0001493152-26-016857.md) | [(1.0)](/filings/0001493152-26-037755.md) | [6.0](/filings/0001493152-26-037755.md) | [4.5](/filings/0001493152-26-037755.md) | [5.7](/filings/0001493152-26-016857.md) | [2.5](/filings/0001493152-26-037755.md) | [2.6](/filings/0001493152-26-037755.md) | [4.7](/filings/0001493152-26-037755.md) | not reported |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(602)](/filings/0001641172-25-013826.md) | [(752) d](/filings/0001493152-26-016849.md) | [(605) d](/filings/0001493152-26-016857.md) | [(330) d](/filings/0001493152-26-016808.md) | [(547)](/filings/0001493152-26-023747.md) | [(3,253) d](/filings/0001493152-26-037755.md) | [(1,249) d](/filings/0001493152-26-016857.md) | [(3,205) d](/filings/0001493152-26-016808.md) | [(2,930)](/filings/0001493152-26-023747.md) | [(3,328) d](/filings/0001493152-26-037755.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | [2.8](/filings/0001493152-26-023747.md) | [45.0 d](/filings/0001493152-26-037755.md) | not reported | not reported | [220](/filings/0001493152-26-023747.md) | [219 d](/filings/0001493152-26-037755.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [28.9](/filings/0001641172-25-013826.md) | [29.0](/filings/0001493152-26-016849.md) | [29.0](/filings/0001493152-26-016857.md) | [29.7](/filings/0001493152-26-023747.md) | [31.5](/filings/0001493152-26-037755.md) | [33.2](/filings/0001493152-26-016857.md) | [36.2](/filings/0001493152-26-023747.md) | [50.1](/filings/0001493152-26-037755.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 51,876,209 at 2026-08-05, from the cover of the [10-Q filed 2026-08-13](/filings/0001493152-26-037755.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.